Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000912282-09-000732
Filing Date
2009-05-18
Accepted
2009-05-15 17:58:30
Documents
1
Effectiveness Date
2009-05-18
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9347
  Complete submission text file 0000912282-09-000732.txt   10789
Mailing Address 1250 WAVERLY STREET, SUITE 5 WINNIPEG A2 R3T 6O6
Business Address 1250 WAVERLY STREET, SUITE 5 WINNIPEG A2 R3T 6O6 (204) 453-1301
Kane Biotech Inc. (Filer) CIK: 0001464368 (see all company filings)

EIN.: 000000000 | State of Incorp.: A2 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-131290 | Film No.: 09834875